Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Open Heart Surgery
NCT06655025Completed
- Sponsor
- Sohag University
- Start
- Oct 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in Post-operative cognitive dysfunction (POCD) and neuronal injury (2 arms), sponsored by Sohag University. Primary endpoint: Serum neuron-specific enolase. Started Oct 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)neuronal injury
Beyond the preview
Go deeper on NCT06655025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06655025.